Cargando…

The Complex Mechanism of Glutamate Dehydrogenase in Insulin Secretion

Detalles Bibliográficos
Autores principales:	Fahien, Leonard A., MacDonald, Michael J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2011
Materias:	Perspectives in Diabetes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3178282/ https://www.ncbi.nlm.nih.gov/pubmed/21948999 http://dx.doi.org/10.2337/db10-1150

Ejemplares similares

Closing in on the Mechanisms of Pulsatile Insulin Secretion
por: Bertram, Richard, et al.
Publicado: (2018)

β-Cell–Specific Gene Repression: A Mechanism to Protect Against Inappropriate or Maladjusted Insulin Secretion?
por: Schuit, Frans, et al.
Publicado: (2012)

Acylcarnitines: Reflecting or Inflicting Insulin Resistance?
por: Schooneman, Marieke G., et al.
Publicado: (2013)

Insulin Regulates Brain Function, but How Does It Get There?
por: Gray, Sarah M., et al.
Publicado: (2014)

Learning From Past Failures of Oral Insulin Trials
por: Michels, Aaron W., et al.
Publicado: (2018)

MicroRNAs in β-Cell Biology, Insulin Resistance, Diabetes and Its Complications
por: Fernandez-Valverde, Selene L., et al.
Publicado: (2011)

Direct Autocrine Action of Insulin on β-Cells: Does It Make Physiological Sense?
por: Rhodes, Christopher J., et al.
Publicado: (2013)

Fatty Acids, Obesity, and Insulin Resistance: Time for a Reevaluation
por: Karpe, Fredrik, et al.
Publicado: (2011)

Targeting Metabolism, Insulin Resistance, and Diabetes to Treat Nonalcoholic Steatohepatitis
por: Finck, Brian N.
Publicado: (2018)

Mineralocorticoid Receptor–Mediated Vascular Insulin Resistance: An Early Contributor to Diabetes-Related Vascular Disease?
por: Bender, Shawn B., et al.
Publicado: (2013)

Hypothalamic Inflammation: Marker or Mechanism of Obesity Pathogenesis?
por: Thaler, Joshua P., et al.
Publicado: (2013)

The Gastrointestinal Tract as an Integrator of Mechanical and Hormonal Response to Nutrient Ingestion
por: Vella, Adrian, et al.
Publicado: (2017)

In Vivo Actions of Peroxisome Proliferator–Activated Receptors: Glycemic control, insulin sensitivity, and insulin secretion
por: Eldor, Roy, et al.
Publicado: (2013)

Nutrient-Sensing Mechanisms in the Gut as Therapeutic Targets for Diabetes
por: Breen, Danna M., et al.
Publicado: (2013)

The “Perfect Storm” for Type 1 Diabetes: The Complex Interplay Between Intestinal Microbiota, Gut Permeability, and Mucosal Immunity
por: Vaarala, Outi, et al.
Publicado: (2008)

Function and Mechanism of Long Noncoding RNAs in Adipocyte Biology
por: Sun, Lei, et al.
Publicado: (2019)

Type 1 Diabetes Prevention: A Goal Dependent on Accepting a Diagnosis of an Asymptomatic Disease
por: Ziegler, Anette-G., et al.
Publicado: (2016)

Chelation: A Fundamental Mechanism of Action of AGE Inhibitors, AGE Breakers, and Other Inhibitors of Diabetes Complications
por: Nagai, Ryoji, et al.
Publicado: (2012)

TRP-ing Down the Path to Insulin Secretion
por: MacDonald, Patrick E.
Publicado: (2011)

The flavor-enhancing action of glutamate and its mechanism involving the notion of kokumi
por: Yamamoto, Takashi, et al.
Publicado: (2023)

Is the Diminished Incretin Effect in Type 2 Diabetes Just an Epi-Phenomenon of Impaired β-Cell Function?
por: Meier, Juris J., et al.
Publicado: (2010)

Glutamate dehydrogenase hyperinsulinism: mechanisms, diagnosis, and treatment
por: Zeng, Qiao, et al.
Publicado: (2023)

Ultra-Rapid-Acting Insulins: How Fast Is Really Needed?
por: Wong, Eva Y., et al.
Publicado: (2021)

Through the Fog: Recent Clinical Trials to Preserve β-Cell Function in Type 1 Diabetes
por: Greenbaum, Carla J., et al.
Publicado: (2012)

Human β-Cell Proliferation and Intracellular Signaling Part 2: Still Driving in the Dark Without a Road Map
por: Bernal-Mizrachi, Ernesto, et al.
Publicado: (2014)

How Do We Move Type 1 Diabetes Immunotherapies Forward During the Current COVID-19 Pandemic?
por: Haller, Michael J., et al.
Publicado: (2021)

Toward a More Complete (and Less Controversial) Understanding of Energy Expenditure and Its Role in Obesity Pathogenesis
por: Kaiyala, Karl J., et al.
Publicado: (2011)

A Role for Glutamate Transporters in the Regulation of Insulin Secretion
por: Gammelsaeter, Runhild, et al.
Publicado: (2011)

OR05-2 Targeted Inhibition of Glutamate Dehydrogenase by Alpha-Tocopherol: A Potential Novel Treatment for Hyperinsulinism Hyperammonemia Syndrome
por: Rosenfeld, Elizabeth, et al.
Publicado: (2019)

It’s Time to Bring Dendritic Cell Therapy to Type 1 Diabetes
por: Creusot, Rémi J., et al.
Publicado: (2014)

Insulin Icodec Weekly: A Basal Insulin Analogue for Type 2 Diabetes
por: Bajaj, Harpreet S, et al.
Publicado: (2023)

Oxoglutarate dehydrogenase complex controls glutamate-mediated neuronal death
por: Weidinger, Adelheid, et al.
Publicado: (2023)

COVID-19–Induced New-Onset Diabetes: Trends and Technologies
por: Metwally, Ahmed A., et al.
Publicado: (2021)

Glutamate is an essential mediator in glutamine‐amplified insulin secretion
por: Han, Guirong, et al.
Publicado: (2021)

Anatomical Locations of Human Brown Adipose Tissue: Functional Relevance and Implications in Obesity and Type 2 Diabetes
por: Sacks, Harold, et al.
Publicado: (2013)

Expectations about and experiences with insulin therapy contribute to diabetes treatment satisfaction in insulin-naïve patients with type 2 diabetes
por: Naegeli, A N, et al.
Publicado: (2010)

Cystic Fibrosis–Related Diabetes Workshop: Research Priorities Spanning Disease Pathophysiology, Diagnosis, and Outcomes
por: Putman, Melissa S., et al.
Publicado: (2023)

Diabetic Retinopathy: Targeting Vasoregression
por: Hammes, Hans-Peter, et al.
Publicado: (2011)

Immune Recognition of β-Cells: Neoepitopes as Key Players in the Loss of Tolerance
por: James, Eddie A., et al.
Publicado: (2018)

Comparative Pathogenesis of Autoimmune Diabetes in Humans, NOD Mice, and Canines: Has a Valuable Animal Model of Type 1 Diabetes Been Overlooked?
por: O’Kell, Allison L., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_cqs4nfqfik067049ju80v17ane